A study in subjects with gout flares that investigates the effect, safety, tolerability, and pharmacokinetics (absorption, distribution, metabolism, and elimination) of a single dose of LEO 158968, a new compound that may potentially be used in the treatment of several autoinflammatory diseases

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508793-29-00

Acronym

LP0189-2318

Enrollment

Registered

2024-09-10

Start date

2025-01-07

Completion date

2025-08-07

Last updated

2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout flares

None listed

Sex/Gender

Male

Age

18 Years to No maximum

France, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026